Fundraising FoxHemovent
acquired by Microport6 known investors
Find your way into Hemovent
Sign up to see every warm intro you have to Hemovent
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemovent team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.
Investors · 6
MIG Capital AGlisted by MIG Capital AGMunich · $1.1M – $10.8M
How we know: MIG Capital AG's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 3
KfW-BankMIG-InvestmentfondsNRW-Bank
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJul 2017
KfW-Bank, MIG-Investmentfonds, NRW-Bank, Seed Fonds Aachen
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Hemovent do?
- Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.
- Who are Hemovent's investors?
- Hemovent's investors include MIG Capital AG, TechVision Fonds, Seed Fonds Aachen.
- Who acquired Hemovent?
- Hemovent was acquired by Microport.